Added to YB: 2025-10-08
Pitch date: 2025-10-05
PFE [neutral]
Pfizer Inc.
-3.54%
current return
Author Info
Disruptive Analytics has 30+ years of experience as a retail investor and is now fully engaged in managing their own money. Sign up for the newsletter.
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$146.5B
Pitch Price
$26.80
Price Target
N/A
Dividend
6.67%
EV/EBITDA
7.56
P/E
14.98
EV/Sales
3.09
Sector
Pharmaceuticals
Category
growth
Targeted Chemotherapy - Pfizer Inc.
PFE (quick overview): $43B Seagen acquisition creates oncology powerhouse with 4 ADC drugs generating $1.5B H1 2025 revenue, potentially $6B+ by 2029. Strong targeted chemo pipeline but large company needs multiple blockbusters for meaningful revenue impact. Timing risk as growth may take longer to materialize than expected.
Read full article (1 min)